MELIS, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 194.156
NA - Nord America 7.853
AS - Asia 3.493
SA - Sud America 648
AF - Africa 106
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 9
Totale 206.309
Nazione #
IT - Italia 192.154
US - Stati Uniti d'America 7.689
SG - Singapore 1.386
CN - Cina 1.113
BR - Brasile 482
SE - Svezia 455
UA - Ucraina 450
VN - Vietnam 298
GB - Regno Unito 228
DE - Germania 220
FI - Finlandia 213
FR - Francia 191
HK - Hong Kong 120
IN - India 117
CA - Canada 102
KR - Corea 65
AR - Argentina 63
BD - Bangladesh 58
NL - Olanda 41
IQ - Iraq 39
PH - Filippine 39
MX - Messico 38
AU - Australia 37
TR - Turchia 33
ZA - Sudafrica 31
EC - Ecuador 26
PL - Polonia 26
AT - Austria 25
JP - Giappone 25
IL - Israele 23
PK - Pakistan 23
ID - Indonesia 21
IE - Irlanda 21
CO - Colombia 20
ES - Italia 20
BE - Belgio 19
MA - Marocco 19
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
MY - Malesia 17
VE - Venezuela 17
CL - Cile 16
IR - Iran 15
RU - Federazione Russa 15
UZ - Uzbekistan 11
KE - Kenya 10
EG - Egitto 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
EU - Europa 8
PY - Paraguay 8
AZ - Azerbaigian 7
CH - Svizzera 7
GR - Grecia 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
AL - Albania 6
BO - Bolivia 6
CR - Costa Rica 6
LK - Sri Lanka 6
LT - Lituania 6
NG - Nigeria 6
TH - Thailandia 6
ET - Etiopia 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
LV - Lettonia 4
NI - Nicaragua 4
OM - Oman 4
PT - Portogallo 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
PS - Palestinian Territory 3
SN - Senegal 3
TW - Taiwan 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
GE - Georgia 2
HN - Honduras 2
MT - Malta 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DM - Dominica 1
GH - Ghana 1
GY - Guiana 1
Totale 206.294
Città #
Cagliari 188.315
Uta 3.432
Fairfield 894
Singapore 700
Ashburn 674
Woodbridge 628
Houston 366
Chandler 348
Seattle 335
Dallas 324
San Jose 323
Ann Arbor 320
Boardman 309
Wilmington 301
Cambridge 283
Nyköping 281
Jacksonville 231
Beijing 216
Dearborn 148
Helsinki 130
The Dalles 125
Los Angeles 121
Hong Kong 106
Ho Chi Minh City 102
Santa Clara 99
Lauterbourg 96
Council Bluffs 93
New York 86
Nanjing 81
Shanghai 80
Boston 77
Hefei 67
Hanoi 65
Buffalo 60
Seoul 59
San Diego 54
Guangzhou 46
Dong Ket 36
London 36
São Paulo 35
Nanchang 34
Munich 33
Milan 32
Redwood City 32
Toronto 32
Hebei 28
Orem 28
Shenyang 26
Frankfurt am Main 25
Tianjin 24
Chicago 23
Jiaxing 22
Redondo Beach 22
Atlanta 21
Dublin 21
Norwalk 20
Changsha 19
Mountain View 19
Rome 19
Chennai 18
Johannesburg 18
Phoenix 17
Tokyo 17
Warsaw 17
Brooklyn 16
Columbus 15
Brussels 14
Melbourne 14
Mumbai 14
Denver 13
Jinan 13
San Francisco 13
Vienna 13
Falls Church 12
Mexico City 12
Santiago 12
Zhengzhou 12
Baghdad 11
Buenos Aires 11
Curitiba 11
Dhaka 11
Guayaquil 11
Kunming 11
Quezon City 11
Tashkent 11
Augusta 10
Belo Horizonte 10
Da Nang 10
Düsseldorf 10
Manchester 10
Montreal 10
Nuremberg 10
Orange 10
Porto Alegre 10
Pune 10
Brasília 9
Lappeenranta 9
Nairobi 9
Philadelphia 9
Sassari 9
Totale 201.055
Nome #
Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain 37.754
Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area 5.423
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.626
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in sardinian alcohol-preferring rats 4.167
Maternal immune activation disrupts dopamine system in the offspring 4.144
Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 3.500
Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis 3.473
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.350
Editorial: Exploring gender and sex differences in behavioral dyscontrol: From drug addiction to impulse control disorders 3.205
Sex differences in addictive disorders 3.169
Physiological role of peroxisome proliferator-activated receptors type alpha on dopamine systems 3.088
Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT2A receptor activation 3.018
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling 3.017
null 2.940
Endocannabinoid signaling in motivation, reward, and addiction: influences on mesocorticolimbic dopamine function 2.735
The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia 2.715
New vistas on cannabis use disorder 2.638
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 2.618
NMDARs mediate the role of monoamine oxidase A in pathological aggression 2.604
Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells 2.584
Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a G alpha(i/o) protein inhibitor 2.547
Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas 2.538
PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission 2.459
PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors 2.451
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system 2.441
null 2.394
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats 2.368
Sex differences in impulsive and compulsive behaviors: a focus on drug addiction 2.343
Interplay between synaptic endocannabinoid signaling and metaplasticity in neuronal circuit function and dysfunction 2.335
Inhibitory inputs from rostromedial tegmental nucleus regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse 2.304
Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: Therapeutic perspectives 2.175
Rehabilitating the addicted brain with transcranial magnetic stimulation 2.094
Altered chloride homeostasis decreases the action potential threshold and increase hyperexcitability in hippocampal neurons 2.031
Dynamic interactions between drugs of abuse and the endocannabinoid system: molecular mechanisms and functional outcome 2.002
Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. 1.853
Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids 1.788
Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission 1.782
ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL 1.773
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.752
Optogenetic inhibition of chemically induced hypersynchronized bursting in mice 1.747
null 1.722
Endocannabinoids and lipid mediators in brain functions 1.712
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.661
Gender differences in the outcome of offspring prenatally exposed to drugs of abuse 1.615
Consequences of Perinatal Cannabis Exposure 1.547
Cannabis and the Developing Brain: Insights into Its Long-Lasting Effects 1.515
Exercise craving potentiates excitatory inputs to ventral tegmental area dopaminergic neurons 1.457
The endocannabinoid system and nondrug rewarding behaviours 1.453
Hub and switches: endocannabinoid signalling in midbrain dopamine neurons 1.445
Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus 1.418
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation 1.388
Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction 1.361
Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure 1.199
Role of 2-arachidonoylglycerol-mediated plasticity at inhibitory synapses onto midbrain dopamine neurons in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.185
Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1-and non-CB1-mediated actions 1.161
Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission 1.143
COR758, a negative allosteric modulator of GABAB receptors 1.134
Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: Evidence for GABAB receptor-mediated effects 1.127
Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons 1.116
I CANNABINOIDI ATTIVANO I NEURONI DOPAMINERGICI DEL SISTEMA MESOLIMBICOCORTICALE 1.115
Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo 1.092
The dopamine hypothesis of drug addiction: hypodopaminergic state 1.085
Endocannabinoids and the processing of value-related signals 1.079
Fatty acid ethanolamides pinpoint nicotinic receptors and modulate neuronal excitability through nuclear receptor PPARα 1.061
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 1.058
Involvement of the endogenus cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: Electrophysiological evidence in vivo 1.035
A role for midbrain 2-arachidonoylglycerol signalling in increased consumption of and preference for ethanol in Sardinian alcohol-preferring rats 1.019
Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement 988
Use of marijuana: effect on brain health and cognitive impairment 967
Chronic morphine and naltrexone fail to modify µ-opioid receptor mRNA levels in the rat brain 938
Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex 910
null 850
Endocannabinoids mediate pre-synaptic inhibition of glutamatergic transmission in rat VTA DA neurons through activation of CB1 receptors 849
null 841
Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate 836
From surface to nuclear receptors: the endocannabinoid family extends its assets 806
null 800
Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure 780
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal 775
Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure 764
null 747
Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders 736
Endocannabinoid signalling in midbrain dopamine neurons: more than physiology? 732
Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation 715
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. 706
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy 699
Presynaptic nanoscale components of retrograde synaptic signaling 682
Ethanol and acetaldehyde action on central dopamine systems: mechanisms,modulation and relation to stress 657
Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system 646
Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system 635
Different mechanism for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain 631
Electrophysiological effects of cannabinoids in the basal ganglia 576
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids 569
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 561
Clozapine potently stimulates mesocortical dopamine neurons 553
COX- Inhibitors increase morphine effects on mesolimbic dopamine neurons 552
Sex-specific susceptibility to psychotic-like states provoked by prenatal THC exposure: Reversal by pregnenolone 546
The cyclo-oxygenase inhibitor nimesulide induce conditioned place preference in rats 529
Mesolimbic dopaminergic decline after cannabinoid withdrawal 529
Clozapine does activate does activate nigrostriatal dopamine neurons in unanesthetized rats 523
Totale 202.476
Categoria #
all - tutte 249.245
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.245


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.067 0 0 0 0 0 0 0 0 0 1.942 1.905 1.220
2021/202211.125 923 872 524 643 961 948 668 629 703 1.176 1.700 1.378
2022/202313.594 1.238 1.520 1.338 1.215 1.305 1.569 711 872 883 978 1.314 651
2023/202448.543 739 651 514 857 1.327 2.142 2.309 829 749 949 1.561 35.916
2024/202526.033 6.404 7.091 2.808 2.691 1.371 1.981 2.092 185 368 242 563 237
2025/20266.863 636 338 1.010 725 512 614 1.286 397 589 756 0 0
Totale 206.683